首页 | 官方网站   微博 | 高级检索  
     

硫利达嗪对乳腺癌细胞MDA-MB-231和MCF-7的杀伤效应
引用本文:童斯浩,汪毅,龚理,钱振珏,柯章敏,鲍扬漪.硫利达嗪对乳腺癌细胞MDA-MB-231和MCF-7的杀伤效应[J].安徽医科大学学报,2015(4).
作者姓名:童斯浩  汪毅  龚理  钱振珏  柯章敏  鲍扬漪
作者单位:1. 安徽医科大学第三附属医院肿瘤科,合肥,230061;2. 安徽医科大学附属省立医院肿瘤科,合肥,230001
摘    要:目的观察硫利达嗪对人乳腺癌细胞MDA-MB-231和MCF-7的凋亡作用,并探讨其机制。方法采用MTT法测定硫利达嗪对细胞的抑制作用,计算半数抑制浓度( IC50);流式细胞术检测硫利达嗪对细胞周期分布和凋亡的影响;比色法测定药物对细胞Caspase-3活性的影响;West-ern blot法检测凋亡调节蛋白Bcl-2、Bax表达的变化。结果
  硫利达嗪作用24 h后, MDA-MB-231、MCF-7细胞增殖明显呈剂量依赖性抑制,其IC50为18、22μmol/L。流式细胞术结果显示,随着加入硫利达嗪浓度的提高, MDA-MB-231、MCF-7细胞均发生不同程度的G0/G1期阻滞、细胞凋亡程度增加及伴随胞内Caspase-3活性增加。各实验组与对照组比较,差异均有统计学意义(P<0.01)。 Western blot法结果显示随着药物浓度的增加,抗凋亡蛋白Bcl-2表达下调、促凋亡蛋白Bax表达明显上调,各实验组与对照组相比,差异有统计学意义( P <0.01)。结论硫利达嗪对乳腺癌细胞MDA-MB-231、MCF-7有显著的增殖抑制作用且可显著诱导肿瘤细胞发生G0/G1期阻滞及凋亡,伴随Caspase-3活性的上调,其毒性机制可能与肿瘤细胞内抗凋亡蛋白 Bcl-2下调、Bax上调有关。

关 键 词:乳腺癌  硫利达嗪  周期  凋亡  Caspase-3  Bcl-2  Bax

Killing effect of thioridazine on the proliferation of breast cancer cells MDA-MB-231 and MCF-7
Abstract:Objectives To investigate the anti-proliferative and apoptosis-inducing effects and the possible molecular mechanisms of thioridazine on breast cancer cell lines MDA-MB-231 and MCF-7. Methods The anti-proliferative effects of thioridazine on MDA-MB-231 and MCF-7 cells were measured with MTT and the values of IC50 were calcu-lated. Flow cytometry was used to measure the cell cycle arresting and apoptosis . Caspase -3 activity assay kit was
performed to detect Caspase-3 activity levels. The expression changes of the Bcl-2 and Bax were detected by western blot. Results After treated with thioridazine for 24 h, MDA-MB-231 and MCF-7 cells were significantly inhibited by the drug extracts. The values of IC50 were respectively 18μmol/L and 22μmol/L. Flow cytometry showed cells’ G0/G1 phase arrest along with an increase of apoptosis and intracellular Caspase-3 activity with the increase of thio-ridazine concentration. Western blot showed concentration-dependant decrease in Bcl-2 and increase in Bax proteins. Each experimental group compared with the control group, the differences were statistically significant (P<0. 01). Conclusion Thioridazine has obvious cytotoxic effect on breast cancer cells MDA-MB-231 and MCF-7. It obviously induces breast cancer cells G0/G1 phase arresting and apoptosis, accompanied by up-regulation of Caspase-3 activity. The mechanism may be related to the down-regulation of Bcl-2 and up-regulation of Bax.
Keywords:breast cancer  thioridazine  cell cycle  apoptosis  Caspase-3  Bcl-2  Bax
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号